Similar articles

• [Hypo- and hyperkalemia. Drugs are usually responsible].

  Stiefelhagen P. Stiefelhagen P. MMW Fortschr Med. 2009 Nov 5;151(45):12-6. MMW Fortschr Med. 2009. PMID: 19960715 German. No abstract available.
• [Diabetogenic effect of drugs].

  Vasilenko VV, Solomatin AS. Vasilenko VV, et al. Sov Med. 1986;(4):50-4. Sov Med. 1986. PMID: 3520872 Review. Russian. No abstract available.
• Hyperkalemia and hyperglycemic increments in plasma potassium in diabetes mellitus.

  Popp D, Achtenberg JF, Cryer PE. Popp D, et al. Arch Intern Med. 1980 Dec;140(12):1617-21. Arch Intern Med. 1980. PMID: 7006540
• Hyperkalaemia, ketoacidosis and subcutaneous or intravenous insulin infusions.

  MacRury SM, Small M, MacCuish AC. MacRury SM, et al. Diabetes Res. 1987 Jul;5(3):153-5. Diabetes Res. 1987. PMID: 3117474
• Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.

  Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Skyler JS, et al. J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008. J Am Coll Cardiol. 2009. PMID: 19147051 Review. No abstract available.